<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="jsp270053" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JOR Spine</journal-id><journal-id journal-id-type="iso-abbrev">JOR Spine</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2572-1143</journal-id><journal-id journal-id-type="publisher-id">JSP2</journal-id><journal-title-group><journal-title>JOR Spine</journal-title></journal-title-group><issn pub-type="epub">2572-1143</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name><publisher-loc>Hoboken, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40012719</article-id><article-id pub-id-type="pmc">PMC11864852</article-id><article-id pub-id-type="doi">10.1002/jsp2.70053</article-id><article-id pub-id-type="publisher-id">JSP270053</article-id><article-id pub-id-type="other">JSP2-24-0232.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Mechanism of Intervertebral Disc Degeneration via the &#x003b2;&#x02010;Catenin/<styled-content style="fixed-case" toggle="no">CCL2</styled-content> Pathway in Sox9 Conditional Knockout Mice</article-title></title-group><contrib-group><contrib id="jsp270053-cr-0001" contrib-type="author"><name><surname>Aboushaala</surname><given-names>Khaled</given-names></name><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jsp270053-cr-0002" contrib-type="author"><name><surname>Chee</surname><given-names>Ana</given-names></name><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jsp270053-cr-0003" contrib-type="author"><name><surname>Ko</surname><given-names>Frank</given-names></name><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jsp270053-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jsp270053-cr-0004" contrib-type="author"><name><surname>Alkhudari</surname><given-names>Jad</given-names></name><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jsp270053-cr-0005" contrib-type="author"><name><surname>Sumughan</surname><given-names>Saurav</given-names></name><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jsp270053-cr-0006" contrib-type="author"><name><surname>An</surname><given-names>Howard S.</given-names></name><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jsp270053-cr-0007" contrib-type="author"><name><surname>Samartzis</surname><given-names>Dino</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7473-1311</contrib-id><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jsp270053-cr-0008" contrib-type="author" corresp="yes"><name><surname>Oh</surname><given-names>Chun&#x02010;do</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5419-8011</contrib-id><xref rid="jsp270053-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>chundo_oh@rush.edu</email></address></contrib></contrib-group><aff id="jsp270053-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Orthopedic Surgery</named-content>
<institution>Rush University Medical Center</institution>
<city>Chicago</city>
<named-content content-type="country-part">Illinois</named-content>
<country country="US">USA</country>
</aff><aff id="jsp270053-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Anatomy and Cell Biology</named-content>
<institution>Rush University Medical Center</institution>
<city>Chicago</city>
<named-content content-type="country-part">Illinois</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Chun&#x02010;do Oh (<email>chundo_oh@rush.edu</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2025</year></pub-date><volume>8</volume><issue seq="248">1</issue><issue-id pub-id-type="doi">10.1002/jsp2.v8.1</issue-id><elocation-id>e70053</elocation-id><history>
<date date-type="rev-recd"><day>20</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>07</day><month>8</month><year>2024</year></date>
<date date-type="accepted"><day>12</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Orthopaedic Research Society--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">JOR Spine</italic> published by Wiley Periodicals LLC on behalf of Orthopaedic Research Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JSP2-8-e70053.pdf"/><abstract><title>ABSTRACT</title><sec id="jsp270053-sec-0001"><title>Introduction</title><p>Degenerative changes in the intervertebral disc (IVD) are known to be a main cause of low back pain (LBP), oftentimes necessitating interventions that may or may not be successful due to a lack of understanding in the degenerative phenotype and its mechanisms. Understanding the molecular mechanisms of disc degeneration can help design new therapies to induce disc regeneration and reduce back pain. This work aimed to understand the effects of conditional deletion of Sox9 in aggrecan&#x02010;expressing cells on intervertebral disc degeneration and its underlying mechanisms in mice.</p></sec><sec id="jsp270053-sec-0002"><title>Methods</title><p>This study utilized <italic toggle="no">Agc1&#x02010;CreERT2;Sox9</italic>
<sup>
<italic toggle="no">flox/flox</italic>
</sup> mice to investigate the effects of SOX9 deletion on IVD degeneration and associated pain behaviors. Mice were administered tamoxifen to induce conditional gene deletion of Sox9. Structural and degenerative phenotypes of the spine were assessed by a histological scoring system and micro&#x02010;computed tomography (microCT). Pain behaviors were evaluated through mechanical allodynia testing and the LABORAS system for spontaneous behavior assessment. Immunohistochemistry identified the expression of proteins of interest, which were further examined by Western blotting. Lastly, quantitative real&#x02010;time PCR and promoter assays on IVD cells were used to examine inflammatory and signaling pathways induced by Sox9 deletion.</p></sec><sec id="jsp270053-sec-0003"><title>Results</title><p>Crossing <italic toggle="no">Agc1&#x02010;CreERT2</italic> mice with <italic toggle="no">Sox9</italic>
<sup>
<italic toggle="no">flox/flox</italic>
</sup> mice revealed that <italic toggle="no">Sox9</italic> conditional deletion (<italic toggle="no">Sox9</italic>
<sup>
<italic toggle="no">cKO</italic>
</sup>) in cartilage tissues causes IVD degeneration and pain behavior. <italic toggle="no">Sox9</italic>
<sup>
<italic toggle="no">cKO</italic>
</sup> mice spines had narrowed intervertebral disc spaces and disorganized IVD tissues. <italic toggle="no">Sox9</italic> deletion also increased &#x003b2;&#x02010;catenin, C&#x02010;C motif chemokine ligand 2 (CCL2), and Glial cell line&#x02010;derived neurotrophic factor (GDNF) expression in the IVD, suggesting their roles in disc pain and degeneration and the importance of the &#x003b2;&#x02010;catenin/CCL2 pathway in these processes.</p></sec><sec id="jsp270053-sec-0004"><title>Conclusions</title><p>Deletion of <italic toggle="no">Sox9</italic> in Aggrecan&#x02010;expressing IVD tissues affects disc degeneration and associated pain behaviors through the &#x003b2;&#x02013;catenin&#x02013;CCL2 pathway. Such findings can lead to more targeted, personalized therapeutics in the future to address discogenic origins of LBP.</p></sec></abstract><abstract abstract-type="graphical"><p>This study investigates the mechanism of intervertebral disc degeneration via the &#x003b2;&#x02010;catenin/CCL2 pathway in Sox9 conditional knockout mice. Our findings reveal that the disruption of Sox9 enhances &#x003b2;&#x02010;catenin activity and CCL2 expression, contributing to disc degeneration.<boxed-text position="anchor" content-type="graphic" id="jsp270053-blkfxd-0001"><graphic xlink:href="JSP2-8-e70053-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jsp270053-kwd-0001">&#x003b2;&#x02010;catenin</kwd><kwd id="jsp270053-kwd-0002">back pain</kwd><kwd id="jsp270053-kwd-0003">CCL2</kwd><kwd id="jsp270053-kwd-0004">disc degeneration</kwd><kwd id="jsp270053-kwd-0005">mechanisms</kwd><kwd id="jsp270053-kwd-0006">molecular</kwd><kwd id="jsp270053-kwd-0007">SOX9</kwd><kwd id="jsp270053-kwd-0008">spine</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Institutes of Health
</institution><institution-id institution-id-type="doi">10.13039/100000002</institution-id></institution-wrap></funding-source><award-id>RO3 AG061460</award-id></award-group><award-group id="funding-0002"><funding-source>Searle Innovation Grant</funding-source></award-group></funding-group><counts><fig-count count="6"/><table-count count="1"/><page-count count="10"/><word-count count="7200"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jsp270053-ntgp-0001"><fn fn-type="funding" id="jsp270053-note-0001"><p>
<bold>Funding:</bold> This work was supported by the National Institutes of Health Grants RO3 AG061460 and Searle Innovation Grant to C.&#x02010;d.O.</p></fn></fn-group></notes></front><body id="jsp270053-body-0001"><sec id="jsp270053-sec-0005"><label>1</label><title>Introduction</title><p>Low back pain is recognized as one of the most prevalent and disabling conditions worldwide, affecting an estimated 80% of the global population with tremendous socioeconomic consequences&#x000a0;[<xref rid="jsp270053-bib-0001" ref-type="bibr">1</xref>, <xref rid="jsp270053-bib-0002" ref-type="bibr">2</xref>, <xref rid="jsp270053-bib-0003" ref-type="bibr">3</xref>, <xref rid="jsp270053-bib-0004" ref-type="bibr">4</xref>, <xref rid="jsp270053-bib-0005" ref-type="bibr">5</xref>]. Given this prevalence and impact, the development of effective therapies has been a longstanding pursuit, and a thorough understanding of pain mechanisms is essential. Although low back pain is multifactorial, intervertebral disc degeneration is a strong etiological factor. The intervertebral disc is composed of a collagen type II matrix dispersed within a proteoglycan&#x02010;rich nucleus pulposus (NP) at the center, and a surrounding collagenous annulus fibrosus (AF) [<xref rid="jsp270053-bib-0006" ref-type="bibr">6</xref>, <xref rid="jsp270053-bib-0007" ref-type="bibr">7</xref>, <xref rid="jsp270053-bib-0008" ref-type="bibr">8</xref>]. Between&#x000a0;the intervertebral discs and vertebrae are interfaces called the vertebral endplates (EPs), which are composed of a&#x000a0;bony layer and a cartilaginous layer [<xref rid="jsp270053-bib-0009" ref-type="bibr">9</xref>]. The main proteoglycan of NP is aggrecan, whose protein is a direct target of SOX9,&#x000a0;as is collagen type II in the NP [<xref rid="jsp270053-bib-0010" ref-type="bibr">10</xref>]. A consequence of intervertebral disc degeneration can lead to &#x0201c;discogenic&#x0201d; origins of pain. This process can be characterized by fissuring or tears of the AF, promoting neurovascular infiltration, disc space narrowing, and perhaps disc bulging or herniation, causing displacement of the disc material and potential compression of the neural elements (e.g., spinal cord, thecal sac, and exiting nerve roots). This process may lead to inflammation in the disc as well as between the disc and the neural interface that may further contribute to the overall symptomology [<xref rid="jsp270053-bib-0011" ref-type="bibr">11</xref>, <xref rid="jsp270053-bib-0012" ref-type="bibr">12</xref>].</p><p>During the development of the mammalian skeleton, chondrocyte differentiation is regulated by SOX9, one of the SRY&#x02010;related HMG&#x02010;box&#x02010;containing proteins, a transcription factor [<xref rid="jsp270053-bib-0013" ref-type="bibr">13</xref>]. SOX9 directly targets several key genes, including <italic toggle="yes">Col2a1</italic> [<xref rid="jsp270053-bib-0014" ref-type="bibr">14</xref>, <xref rid="jsp270053-bib-0015" ref-type="bibr">15</xref>], <italic toggle="yes">Col11a2</italic> [<xref rid="jsp270053-bib-0016" ref-type="bibr">16</xref>], <italic toggle="yes">Acan</italic> [<xref rid="jsp270053-bib-0010" ref-type="bibr">10</xref>], <italic toggle="yes">CD&#x02010;rap</italic> [<xref rid="jsp270053-bib-0017" ref-type="bibr">17</xref>], <italic toggle="yes">Ctgf</italic> [<xref rid="jsp270053-bib-0018" ref-type="bibr">18</xref>], and so forth, which are essential for chondrocyte differentiation [<xref rid="jsp270053-bib-0019" ref-type="bibr">19</xref>]. Heterozygous mutations in <italic toggle="yes">Sox9</italic> cause Campomelic Dysplasia (CD), a generalized disease of cartilage characterized by hypoplasia of endochondral bones [<xref rid="jsp270053-bib-0020" ref-type="bibr">20</xref>, <xref rid="jsp270053-bib-0021" ref-type="bibr">21</xref>]. This phenotype has also been observed in mouse models of conditional inactivation of the <italic toggle="yes">Sox9</italic> gene [<xref rid="jsp270053-bib-0022" ref-type="bibr">22</xref>, <xref rid="jsp270053-bib-0023" ref-type="bibr">23</xref>].</p><p>Since the main components of the intervertebral disc are aggrecan and collagens, SOX9 is considered an essential transcription factor for the proper development and maintenance of the intervertebral disc [<xref rid="jsp270053-bib-0024" ref-type="bibr">24</xref>, <xref rid="jsp270053-bib-0025" ref-type="bibr">25</xref>, <xref rid="jsp270053-bib-0026" ref-type="bibr">26</xref>]. One of the radiologic manifestations of Campomelic Dysplasia (CD) includes short and somewhat flattened vertebrae [<xref rid="jsp270053-bib-0027" ref-type="bibr">27</xref>]. In addition, the postnatal conditional inactivation of <italic toggle="yes">Sox9</italic> leads to intervertebral disc degeneration [<xref rid="jsp270053-bib-0028" ref-type="bibr">28</xref>].</p><p>Furthermore, as skeletal progenitors differentiate into chondrocytes or osteoblasts, SOX9 acts as a master regulator of chondrocyte differentiation. It is worth noting that in this segregation process, &#x003b2;&#x02010;catenin, the functional factor of canonical Wnt&#x02010;signaling, is inhibited by SOX9 [<xref rid="jsp270053-bib-0029" ref-type="bibr">29</xref>, <xref rid="jsp270053-bib-0030" ref-type="bibr">30</xref>, <xref rid="jsp270053-bib-0031" ref-type="bibr">31</xref>]. A recent detailed study employing postnatal conditional <italic toggle="yes">Sox9</italic> knockout models has demonstrated that <italic toggle="yes">Sox9</italic> deletion leads to disc degeneration and induces or suppresses genes related to the Wnt/LRP6 signaling, inflammation, chemokines, and extracellular matrix proteins [<xref rid="jsp270053-bib-0032" ref-type="bibr">32</xref>]. However, whether these molecular mechanisms are associated with pain has not been examined. In this study, we therefore employed the <italic toggle="yes">Sox9</italic> conditional knockout mouse to elucidate the relationship between intervertebral disc degeneration and pain behavior, as well as to identify the specific signaling pathways implicated in this process. Our findings provide novel insights into the pathophysiology of intervertebral disc degeneration and its associated pain. We demonstrate that the <italic toggle="yes">Sox9</italic> regulation of &#x003b2;&#x02010;catenin, CCL2, and GDNF constitutes a pivotal mechanism in pain signaling, suggesting that modulation of this pathway may represent a promising therapeutic strategy for intervertebral disc degeneration and its concomitant pain.</p></sec><sec sec-type="materials-and-methods" id="jsp270053-sec-0006"><label>2</label><title>Materials and Methods</title><sec id="jsp270053-sec-0007"><label>2.1</label><title>Mice and Deletion of <styled-content style="fixed-case" toggle="no">SOX9</styled-content> Using Agc1&#x02010;<styled-content style="fixed-case" toggle="no">CreERT2</styled-content>; <italic toggle="no">Sox9</italic>
<sup>
<italic toggle="no">flox/flox</italic>
</sup>
</title><p>
<italic toggle="yes">Agc1&#x02010;CreERT2</italic> mice with <italic toggle="yes">ROSA</italic>
<sup>
<italic toggle="yes">mTmG</italic>
</sup> reporter (#019148, #007676) were obtained from Jackson Laboratory (Bar Harbor, ME, USA). The <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> mice (#013106) were described previously [<xref rid="jsp270053-bib-0018" ref-type="bibr">18</xref>]. To assess the expression of <italic toggle="yes">Agc1&#x02010;CreERT2</italic> in the intervertebral disc, <italic toggle="yes">Agc1&#x02010;CreERT2;ROSA</italic>
<sup>
<italic toggle="yes">mTmG</italic>
</sup> mice were administered by intraperitoneal (I.P.) injection (1&#x02009;mg/10&#x02009;g body weight for 5 consecutive days) with tamoxifen (Sigma&#x02013;Aldrich Inc.) at 2&#x02009;weeks of age and sacrificed at the age of 4&#x02009;weeks. To determine the effects of Sox9 deletion on the intervertebral disc, <italic toggle="yes">Agc1&#x02010;CreERT2</italic> mice were crossed with <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> mice. The resulting <italic toggle="yes">Agc1&#x02010;CreERT2;Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> mice were administered tamoxifen (1&#x02009;mg/10&#x02009;g body weight IP, daily for 5&#x02009;days) at 8&#x02009;weeks of age and sacrificed at the age of 16&#x02009;weeks, presented as <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>. In the control group, which consisted of <italic toggle="yes">Cre</italic>&#x02010;negative mice, corn oil was injected intraperitoneally using the identical volume. The experimental and control groups were not randomly assigned but instead allocated according to the genotype. All the subsequent procedures and downstream analyses were performed by blinded observers. The animal protocol of this study has been approved by the IACUC of Rush University, and all experimental methods and procedures were carried out in accordance with the approved guidelines. Mice were maintained in a pathogen&#x02010;free facility, subjected to a 12/12&#x02009;h light/dark cycle, and had ad&#x000a0;libitum access to standard laboratory rodent chow and water.</p></sec><sec id="jsp270053-sec-0008"><label>2.2</label><title>Histological Analysis</title><p>The disc tissue was dissected from 4&#x02010;month&#x02010;old <italic toggle="yes">Cre</italic>&#x02010;negative (<italic toggle="yes">Cre&#x02212;</italic>) and <italic toggle="yes">Agc1&#x02010;CreERT2;Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> (<italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>) mice from the 2 experimental groups described in Figure&#x000a0;<xref rid="jsp270053-fig-0001" ref-type="fig">1</xref>. Samples were fixed in 10% formalin, decalcified in 14% EDTA, and embedded in paraffin. Paraffin&#x02010;embedded samples were sectioned at 8&#x02009;&#x003bc;m thickness. Histologic/structural changes in disc tissue (L4/5) were evaluated by Alcian blue/hematoxylin and eosin (AB/H&#x00026;E).</p><fig position="float" fig-type="FIGURE" id="jsp270053-fig-0001"><label>FIGURE 1</label><caption><p>Deletion of Sox9 leads to severe disc defects. (A) Histological analysis (Alcian blue/H&#x00026;E staining, L4/5, <italic toggle="yes">Cre&#x02212;</italic>, <italic toggle="yes">n</italic>&#x02009;=&#x02009;3, <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5, scale bar 100&#x02009;&#x003bc;m) showing that growth plate cartilage was slightly narrow (yellow arrow). Disc tissue including NP and AF was dramatically disorganized (pink arrow) and hypertrophic cells were shown adjacent to end plate area (red arrow). Agc&#x02010;CreER mice were bred with Sox9 flox/fox mice. The resulting <italic toggle="yes">Agc1&#x02010;CreER;Sox9 floxflox</italic> mice were administered with tamoxifen (1&#x02009;mg/10&#x02009;g body weight IP, daily for 5&#x02009;days) at 8&#x02009;weeks of age and sacrificed at the ages of 16&#x02010;week&#x02010;old, presented as <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>. (B) Histological grading assessment was quantitatively measured and represent mean&#x02009;&#x000b1;&#x02009;SD. Statistical analysis was conducted using two tailed unpaired <italic toggle="yes">t</italic>&#x02010;test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="JSP2-8-e70053-g003" position="anchor" id="jats-graphic-3"/></fig><p>Histological grading was determined using the scoring methods described previously [<xref rid="jsp270053-bib-0033" ref-type="bibr">33</xref>]. Tamoxifen induction was performed when mice were at 8&#x02009;weeks of age. For the histomorphometric analysis, NP, AF, and cartilage endplate areas of 4&#x02010;month&#x02010;old mice were analyzed.</p></sec><sec id="jsp270053-sec-0009"><label>2.3</label><title>Plasmid Construction and Reporter Assay</title><p>To show a direct effect of the &#x003b2;&#x02010;catenin/TCF pathway on <italic toggle="yes">Ccl2</italic> expression, we have generated the human <italic toggle="yes">Ccl2</italic> promoter construct by subcloning a 3.8&#x02009;kb fragment of the 5&#x02032; promoter region (GI access number; 516772) into the firefly luciferase reporter plasmid pGL&#x02010;3 (Promega) [<xref rid="jsp270053-bib-0034" ref-type="bibr">34</xref>].</p><p>This human <italic toggle="yes">Ccl2</italic> promoter contains a consensus &#x003b2;&#x02010;catenin/TCF binding site (5&#x02032;&#x02010;CTTTGTA&#x02010;3&#x02032;) located 1,399 bp upstream of the transcription initiation start. A mutated human <italic toggle="yes">Ccl2</italic> promoter reporter construct was generated by mutating the &#x003b2;&#x02010;catenin/TCF binding site (5&#x02032;&#x02010;CTTTGGC&#x02010;3&#x02032;). Transient transfection experiments were conducted using Fugene&#x02010;6 transfection reagent (Roche Diagnostic) on rat immortalized NP and AF cells. Twenty&#x02010;four hours post&#x02010;transfection using the wild&#x02010;type or the mutated rat <italic toggle="yes">Ccl2</italic> promoter, the cells were treated with 1&#x02009;&#x003bc;M BIO (the small molecule glycogen synthase kinase&#x02010;3 inhibitor, and 6&#x02010;bromoindirubin&#x02010;3&#x02032;&#x02010;oxime) to activate &#x003b2;&#x02010;catenin for 24&#x02009;h [<xref rid="jsp270053-bib-0026" ref-type="bibr">26</xref>, <xref rid="jsp270053-bib-0034" ref-type="bibr">34</xref>]. For each experiment, firefly luciferase activity was normalized to the renilla luciferase activity, which served as an internal control. The results were expressed as fold changes, determined by normalizing each firefly luciferase value to the renilla luciferase internal control value. Each experiment was performed in triplicate and repeated at least three times. Since the results from NP and AF cells are similar, we present the data collectively as disc cells in Figure&#x000a0;<xref rid="jsp270053-fig-0005" ref-type="fig">5E</xref>.</p></sec><sec id="jsp270053-sec-0010"><label>2.4</label><title>Micro&#x02010;Computed Tomography (<styled-content style="fixed-case" toggle="no">mCT</styled-content>) Analysis</title><p>Formalin&#x02010;fixed spine tissues from 4&#x02010;month&#x02010;old mice from the 2 experimental groups were evaluated by &#x003bc;CT using a Scanco &#x003bc;CT35 scanner. Spine samples were scanned at 12&#x02010;&#x003bc;m resolution with a slice increment of 10&#x02010;&#x003bc;m. Images from each group were reconstructed at identical thresholds to allow for a 3&#x02010;dimensional structural rendering of each spine sample.</p><p>Changes in disc space height L3/4 and L4/5 of 4&#x02010;month&#x02010;old mice were measured. The average Disc height index (DHI) was determined by measurements obtained from the anterior, middle, and posterior portions of the IVD and then dividing this average by the mean height of the adjacent vertebral bodies, as described previously using radiographs&#x000a0;[<xref rid="jsp270053-bib-0035" ref-type="bibr">35</xref>, <xref rid="jsp270053-bib-0036" ref-type="bibr">36</xref>].</p></sec><sec id="jsp270053-sec-0011"><label>2.5</label><title>Pain Assessment</title><p>The mechanical allodynia test was performed using a calibrated set of von Frey filaments (North Coast Medical Inc., CA, USA). Pain&#x02010;related behavior tests were performed in 3&#x02010;month&#x02010;old mice. Prior to the von Frey hind paw test, the mice were allowed to accommodate for 15&#x02009;min on a wire mesh grid. The filaments (typical force range used in mice is from 0.04 to 6.0&#x02009;g, beginning with 0.4&#x02009;g) were applied to the plantar surface of the hind paw to determine the 50% force withdrawal threshold using the classical up&#x02010;down iterative method as previously described [<xref rid="jsp270053-bib-0037" ref-type="bibr">37</xref>]. The tests were performed in a blinded manner. The assessment of spontaneous behavior was measured by the Laboratory Animal Behavior Observation Registration and Analysis System (LABORAS, Metris, the Netherlands). Briefly, after the animals were weighed, the mice were placed in separate platforms for 15&#x02009;h from 18:00&#x02009;p.m. to 9:00&#x02009;a.m. the next day. The following parameters were assessed: distance of locomotion, average speed of locomotion, rearing frequency, and rearing duration.</p></sec><sec id="jsp270053-sec-0012"><label>2.6</label><title>Immunohistochemistry</title><p>The disc tissue was dissected from <italic toggle="yes">Cre</italic>&#x02010;negative (<italic toggle="yes">Cre&#x02212;</italic>) and <italic toggle="yes">Agc1&#x02010;CreERT2;Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> (<italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>) mice. Samples were fixed in 10% formalin, decalcified in 14% EDTA, and embedded in paraffin. Paraffin sections (8&#x02009;&#x003bc;M) were boiled for 15&#x02009;min in citrate buffer to reverse cross&#x02010;links and unmask epitopes. Sections were blocked with 5% goat serum for 1&#x02009;h and incubated with anti&#x02010;&#x003b2;&#x02010;catenin (Abcam, #ab16051) or anti&#x02010;CCL2 (Novus, #NB2&#x02010;22115) or anti&#x02010;GDNF (Santa Cruz, #sc&#x02010;13147) at a dilution of 1:200 overnight at 4&#x000b0;C. The following day, sections were incubated with biotinylated goat anti&#x02010;rabbit or anti&#x02010;mouse antibody for 30&#x02009;min, followed by incubation with the VECTASTAIN Elite ABC Reagent. ImmPACT DAB Peroxidase Substrate was used to reveal IHC signals, which were then analyzed with the ImageJ program. We stained all disc levels; however, L4/5 was selected as the representative data for the figures and analysis. To address the potential issue of non&#x02010;specific binding of the secondary anti&#x02010;mouse antibody to endogenous mouse IgG, we compared staining results with and without the primary antibody while using the secondary anti&#x02010;mouse antibody. The absence of staining in the no&#x02010;primary antibody control confirms that our staining is specific for the primary antibody.</p></sec><sec id="jsp270053-sec-0013"><label>2.7</label><title>Cell Cultures</title><p>The immortalized rat NP and AF cells were cultured with Dulbecco's modified Eagle's medium (DMEM)/Ham's F&#x02010;12 (1:1) (Gibco, Gaithersburg, MD) supplemented with 20% fetal bovine serum (FBS) (Gibco, Gaithersburg, MD) and 1% (vol/vol) penicillin and streptomycin in a 37&#x000b0;C, 5% CO<sub>2</sub> atmosphere [<xref rid="jsp270053-bib-0026" ref-type="bibr">26</xref>]. The cell lines were treated with 1&#x02009;&#x003bc;M BIO or 5&#x02009;ng/mL IL&#x02010;1&#x003b2; for 24&#x02009;h; then, RT&#x02010;qPCR and western blot were performed.</p></sec><sec id="jsp270053-sec-0014"><label>2.8</label><title>Western Blot Analysis</title><p>After washing with PBS twice, immortalized cells were lysed using RIPA buffer (10&#x02009;mM Tri&#x02010;HCl, pH 7.4, 0.01% sodium dodecyl sulfate (SDS), and 0.1% Nonidet P&#x02010;40 with protease inhibitors). The lysate protein concentration was measured by BCA protein assay and standardized by total protein using sample buffer (Bio&#x02010;Rad, Hercules, CA, USA). The samples were separated by SDS&#x02010;10% polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The membrane was blocked with milk in PBS, treated with primary antibody, washed, and incubated with horseradish peroxidase&#x02010;conjugated secondary antibody. The primary antibodies, mouse anti&#x02010;&#x003b2;&#x02010;catenin antibody (Abcam, #ab16051) at a 1:100 dilution and mouse anti&#x02010;&#x003b2;&#x02010;actin antibody (Santa Cruz, #sc&#x02010;517582) at a 1:200 dilution, were incubated with the membranes for 2&#x02009;h. After washes, the protein bands were visualized by an ECL detection kit (Thermofisher Scientific) under x&#x02010;ray exposure.</p></sec><sec id="jsp270053-sec-0015"><label>2.9</label><title>Quantitative Real Time <styled-content style="fixed-case" toggle="no">qPCR</styled-content>
</title><p>Total RNA was extracted from rat NP or AF cells and analyzed by RT&#x02010;qPCR [<xref rid="jsp270053-bib-0026" ref-type="bibr">26</xref>] using the RNeasy Plus Mini Kit (QIAGEN) according to the manufacturer's protocol. cDNA was prepared from the mRNA using the iScript cDNA synthesis kit (Bio&#x02010;rad). Quantitative polymerase chain reaction (qPCR) was performed using primers specific for each RNA, SYBR Master Mix, and a BIO&#x02010;rad CFX96 system. The difference in Ct values (delta Ct) between the Ct value of each sample and that of GAPDH was calculated. The delta Ct value of each gene was then compared to that of each sample. Comparison of mRNA expression of specific genes between control and BIO treatment were performed. Specific PCR primer names and sequences for real&#x02010;time PCR are listed in Table&#x000a0;<xref rid="jsp270053-tbl-0001" ref-type="table">1</xref>.</p><table-wrap position="float" id="jsp270053-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Primer sequences for PCR.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Primers</th><th align="center" valign="bottom" rowspan="1" colspan="1">Forward (5&#x02032;&#x02010;3&#x02032;)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Reverse (5&#x02032;&#x02010;3&#x02032;)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Ccl2</td><td align="center" valign="top" rowspan="1" colspan="1">GAATGAGTAGCAGCAGGTGAG</td><td align="center" valign="top" rowspan="1" colspan="1">ATCTCTCTTCCTCCACCACTA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ccl3</td><td align="center" valign="top" rowspan="1" colspan="1">GGAATTTGCCGTCCATAGGA</td><td align="center" valign="top" rowspan="1" colspan="1">GCCCTTGCTGTTCTTCTCT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ccl5</td><td align="center" valign="top" rowspan="1" colspan="1">GGAGAGGTAGGCAAAGCAG</td><td align="center" valign="top" rowspan="1" colspan="1">CATCTTCCACAGTCTCTGCTTC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR1</td><td align="center" valign="top" rowspan="1" colspan="1">GGAACTGGTCAGGAACAATAGC</td><td align="center" valign="top" rowspan="1" colspan="1">GAACCTTGAATTCATAAAGACTCTCA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR2</td><td align="center" valign="top" rowspan="1" colspan="1">GACCGAGTGAGCTCAACATTT</td><td align="center" valign="top" rowspan="1" colspan="1">AACCCAACTGAGACTTCTTGC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#x02010;1&#x003b2;</td><td align="center" valign="top" rowspan="1" colspan="1">CACCTTCTTTTCCTTCATCTTTG</td><td align="center" valign="top" rowspan="1" colspan="1">GTCGTTGCTTGTCTCTCCTTGTA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tnf&#x02010;&#x003b1;</td><td align="center" valign="top" rowspan="1" colspan="1">ACTGAACTTCGGGGTGATTG</td><td align="center" valign="top" rowspan="1" colspan="1">GCTTGGTGGTTTGCTACGAC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mmp13</td><td align="center" valign="top" rowspan="1" colspan="1">GCAGCTCCAAAGGCTACAA</td><td align="center" valign="top" rowspan="1" colspan="1">CATCATCTGGGAGCATGAAA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gapdh</td><td align="center" valign="top" rowspan="1" colspan="1">CCACAGTCCATGCCATCAC</td><td align="center" valign="top" rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTA</td></tr></tbody></table></table-wrap></sec><sec id="jsp270053-sec-0016"><label>2.10</label><title>Statistical Analysis</title><p>Sample size estimates were based on our prior studies [<xref rid="jsp270053-bib-0026" ref-type="bibr">26</xref>] and the statistical analyses were done in consultation with the Rush University Biostatistics Core. We used student's <italic toggle="yes">t</italic>&#x02010;test or ANOVA to compare the experimental groups. When <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 from ANOVA, we performed Tukey's HSD post&#x02010;hoc comparisons. A similar approach was used for the molecular data. All analyses were performed using the statistical software GraphPad Prism version 10.2.1.(331).</p></sec></sec><sec sec-type="results" id="jsp270053-sec-0017"><label>3</label><title>Results</title><sec id="jsp270053-sec-0018"><label>3.1</label><title>
<italic toggle="no">Agc1&#x02010;<styled-content style="fixed-case" toggle="no">CreERT2</styled-content>
</italic> Targets Different Types of Tissues in the Intervertebral Disc</title><p>To determine whether <italic toggle="yes">Agc1&#x02010;CreERT2</italic> works in the presence of tamoxifen, <italic toggle="yes">Agc1</italic>&#x02010;<italic toggle="yes">CreERT2</italic> mice were bred with ROSA<sup>
<italic toggle="yes">mTmG</italic>
</sup> reporter mice to generate <italic toggle="yes">Agc1</italic>&#x02010;<italic toggle="yes">CreERT2</italic>;ROSA<sup>
<italic toggle="yes">mTmG</italic>
</sup> mice. ROSA<sup>
<italic toggle="yes">mTmG</italic>
</sup> mice expressed red fluorescence in various parts of the intervertebral disc and vertebra, including the growth plate (GP), NP, and AF (Figure&#x000a0;<xref rid="jsp270053-supitem-0001" ref-type="supplementary-material">S1</xref>, Left Panel). After tamoxifen administration to 2&#x02010;week&#x02010;old <italic toggle="yes">Agc1</italic>&#x02010;<italic toggle="yes">CreERT2</italic>;ROSA<sup>
<italic toggle="yes">mTmG</italic>
</sup> mice, enhanced green fluorescent protein (<italic toggle="yes">mG</italic>) exhibiting green fluorescence was observed in the growth plate (GP), NP, and inner AF at 4&#x02010;week&#x02010;old mice, indicating the <italic toggle="yes">Agc1&#x02010;CreER</italic> activation and the successful deletion of the floxed stop codon of tdTomato (<italic toggle="yes">mT</italic>) genes in regions where Aggrecan is expressed (Figure&#x000a0;<xref rid="jsp270053-supitem-0001" ref-type="supplementary-material">S1</xref>, Right Panel). In addition, the EP tissue also showed green fluorescence but was less intense compared to other disc tissues. This supports our use of Agc1&#x02010;CreERT2 to conditionally delete Sox9 in the intervertebral disc to explore the signaling pathways involved in disc degeneration and associated pain mechanisms.</p></sec><sec id="jsp270053-sec-0019"><label>3.2</label><title>Deletion of Sox9 Leads to Severe Defects in the Intervertebral Disc</title><p>
<italic toggle="yes">Agc1&#x02010;CreERT2/Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> mice were treated with tamoxifen at 8&#x02009;weeks of age and sacrificed at 16&#x02009;weeks of age to generate <italic toggle="yes">Sox9</italic> conditional knockout (<italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>) in tissues where aggrecan is expressed. The harvested tissues, including the intervertebral disc, were stained with Alcian blue/H&#x00026;E. The growth plate cartilage in the <italic toggle="yes">Sox9</italic> conditional knockout mice was slightly narrower compared to the control (Figure&#x000a0;<xref rid="jsp270053-fig-0001" ref-type="fig">1A</xref>). Specifically, the NP tissue in <italic toggle="yes">Agc1&#x02010;CreERT2/Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> mice exhibited a fibrous structure, reduced cell numbers, empty lacunae without cells, and severe matrix disorganization. Furthermore, the disc tissue, encompassing the NP and AF, exhibited significant disorganization and the presence of hypertrophic cells near the EP area. The AF tissue displayed a marked loss of normal lamellar organization, and the interface region showed undefined boundaries between the NP&#x02013;AF and EP&#x02013;AF, suggesting that <italic toggle="yes">Sox9</italic> conditional deletion leads to intervertebral disc degeneration.</p><p>Histopathological grading was assessed and quantitated in Figure&#x000a0;<xref rid="jsp270053-fig-0001" ref-type="fig">1B</xref>, and microfractures in the NP and AF tissue were not scored due to artifacts introduced during histological preparation.</p></sec><sec id="jsp270053-sec-0020"><label>3.3</label><title>The Narrowing of the Intervertebral Disc and Pain Behavior Were Observed in Sox9 Conditional Knockout Mice</title><p>Micro&#x02010;CT representative images qualitatively showed that the disc space was reduced in <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice (Figure&#x000a0;<xref rid="jsp270053-fig-0002" ref-type="fig">2A</xref>). We quantitatively measured the average disc height and found significant reductions in DHI indices (Figure&#x000a0;<xref rid="jsp270053-fig-0002" ref-type="fig">2B</xref>). As shown in Figure&#x000a0;<xref rid="jsp270053-fig-0002" ref-type="fig">2C</xref>, <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5) demonstrated significantly lower withdrawal thresholds compared to control mice (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5), indicating increased sensitivity to mechanical stimuli (*<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01). Moreover, the LABORAS assessment revealed significant differences between control mice and <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice, specifically reduced rearing frequency, travel distance, average walking speed, and rearing duration (Figure&#x000a0;<xref rid="jsp270053-fig-0002" ref-type="fig">2D</xref>). Subsequently, the molecular mechanisms underlying pain associated with intervertebral disc degeneration due to <italic toggle="yes">Sox9</italic> deletion were examined.</p><fig position="float" fig-type="FIGURE" id="jsp270053-fig-0002"><label>FIGURE 2</label><caption><p>Disc defect and pain behavior were observed in Sox9 deletion mice. (A, B) &#x003bc;CT analyses were performed in 2 groups of mice; (1) <italic toggle="yes">Cre&#x02212;</italic>, (2) <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice. Deletion of Sox9 showed the phenotype of disc space narrowing (yellow arrows). (B) Average disc height index was calculated by measuring the disc height of L3/4 and L4/5 (<italic toggle="yes">Cre&#x02212;</italic>, <italic toggle="yes">n</italic>&#x02009;=&#x02009;4, <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>, <italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (C, D) Pain&#x02010;related behavior tests were performed in 3&#x02010;month&#x02010;old mice. The results of Von frey threshold, rearing frequency, travel distance, average walking speed and rearing duration showed that <italic toggle="yes">Sox&#x02010;9</italic> deletion mice have high pain sensitivity (<italic toggle="yes">Cre&#x02212;</italic>, <italic toggle="yes">n</italic>&#x02009;=&#x02009;4, <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup>, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5). *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ****<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, two&#x02010;way ANOVA followed by Turkey HSD test, compared to <italic toggle="yes">Cre</italic>&#x02010;negative control mice.</p></caption><graphic xlink:href="JSP2-8-e70053-g005" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="jsp270053-sec-0021"><label>3.4</label><title>
<styled-content style="fixed-case" toggle="no">GDNF</styled-content> Expression Increased in the <styled-content style="fixed-case" toggle="no">NP</styled-content> and <styled-content style="fixed-case" toggle="no">EP</styled-content> Areas in <italic toggle="no">Sox9</italic> Deletion Mice</title><p>GDNF (Glial&#x02010;cell&#x02010;line&#x02010;derived neurotrophic factor) and its receptors were previously demonstrated to be upregulated in the cell line of human intervertebral discs degenerated by IL&#x02010;1&#x003b2; treatment [<xref rid="jsp270053-bib-0038" ref-type="bibr">38</xref>]. To investigate the regulation of GDNF during intervertebral disc degeneration and its potential contribution to associated pain, we analyzed its expression in disc tissues. Figure&#x000a0;<xref rid="jsp270053-fig-0003" ref-type="fig">3A</xref> illustrates that GDNF was highly expressed in the NP and EP areas of <italic toggle="yes">Sox9</italic>&#x02010;deficient disc tissues. The levels of GDNF expression were quantified across different areas, including NP, EP, and AF, and the results are depicted in Figure&#x000a0;<xref rid="jsp270053-fig-0003" ref-type="fig">3B</xref>. Detailed visualizations of GDNF expression in these specific regions are provided in the high&#x02010;magnification images of Figure&#x000a0;<xref rid="jsp270053-fig-0003" ref-type="fig">3C</xref>.</p><fig position="float" fig-type="FIGURE" id="jsp270053-fig-0003"><label>FIGURE 3</label><caption><p>GDNF expression increased in the NP and EP areas in <italic toggle="yes">Sox9</italic> deletion mice. Representative images of immunohistological staining (L4/5, <italic toggle="yes">n</italic>&#x02009;=&#x02009;3, scale bar 100&#x02009;&#x003bc;m in A, 25&#x02009;&#x003bc;m in C) with GDNF showing <italic toggle="yes">Aggrecan</italic> targeting intervertebral disc in two group mice (1) <italic toggle="yes">Cre&#x02212;</italic>, (2) <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice. GDNF&#x02010;positive cells were detected in NP and EP areas in <italic toggle="yes">Sox9</italic> deletion mice (A) and magnified images were presented (C). (B) Quantitative measurements represent mean&#x02009;&#x000b1;&#x02009;SD. Statistical analysis was conducted using a two&#x02010;tailed unpaired <italic toggle="yes">t</italic>&#x02010;test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05. Arrowheads indicate a positive signal. AF: annulus fibrosus, EP: endplate, NP: nucleus pulposus.</p></caption><graphic xlink:href="JSP2-8-e70053-g002" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="jsp270053-sec-0022"><label>3.5</label><title>Activation of &#x003b2;&#x02010;Catenin/<styled-content style="fixed-case" toggle="no">CCL2</styled-content> Is Associated With Intervertebral Disc Degeneration and Increased Pain Behavior</title><p>Since <italic toggle="yes">Sox</italic>9 normally represses the function of &#x003b2;&#x02010;catenin in the Wnt signaling pathway during the differentiation of common progenitors into chondrocytes and osteoblasts [<xref rid="jsp270053-bib-0023" ref-type="bibr">23</xref>, <xref rid="jsp270053-bib-0031" ref-type="bibr">31</xref>], its deletion may lead to elevated &#x003b2;&#x02010;catenin levels in the intervertebral discs. We therefore examined &#x003b2;&#x02010;catenin levels in <italic toggle="yes">Sox9</italic>&#x02010;deleted intervertebral disc tissue (Figure&#x000a0;<xref rid="jsp270053-fig-0004" ref-type="fig">4</xref>, Upper panel). As expected, a significant increase in &#x003b2;&#x02010;catenin was observed in the degenerated intervertebral discs. To determine the molecular mechanism by which &#x003b2;&#x02010;catenin regulates downstream target genes, we examined CCL2 expression in Sox9&#x02010;deleted intervertebral disc tissue since CCL2 serves as a ligand for the chemokine receptor CCR2, which plays a critical role in leukocyte migration during inflammation [<xref rid="jsp270053-bib-0039" ref-type="bibr">39</xref>, <xref rid="jsp270053-bib-0040" ref-type="bibr">40</xref>] and has been shown to play important roles in osteoarthritis (OA) development and OA pain [<xref rid="jsp270053-bib-0041" ref-type="bibr">41</xref>]. We found that CCL2 levels were elevated in the degenerated discs (Figures&#x000a0;<xref rid="jsp270053-fig-0004" ref-type="fig">4</xref> and <xref rid="jsp270053-fig-0005" ref-type="fig">5</xref>). In addition, previous RNA&#x02010;seq analysis comparing <italic toggle="yes">Sox9</italic> deletion with control cells showed a significant upregulation of <italic toggle="yes">Ccl2</italic> expression in Sox9&#x02010;deleted chondrocytes (Figure&#x000a0;<xref rid="jsp270053-supitem-0001" ref-type="supplementary-material">S2</xref>) [<xref rid="jsp270053-bib-0042" ref-type="bibr">42</xref>]. To elucidate the downstream target genes in disc cells, we then analyzed changes in the expression of multiple genes that have been reported to be involved in disc degeneration [<xref rid="jsp270053-bib-0038" ref-type="bibr">38</xref>]. We found that the most significantly upregulated genes by BIO were <italic toggle="yes">Mmp13</italic> and <italic toggle="yes">Ccl2</italic> in AF and NP cells (Figure&#x000a0;<xref rid="jsp270053-fig-0005" ref-type="fig">5A,B</xref>). We then examined if the Wnt/&#x003b2;&#x02010;catenin/Tcf4 complex directly upregulates C&#x02010;C motif chemokine ligand 2 (<italic toggle="yes">Ccl2</italic>). We cloned a 2.5&#x02009;kb long rat <italic toggle="yes">Ccl2</italic> promoter and found that there are conserved &#x003b2;&#x02010;catenin/TCF binding sites. Treatment of BIO significantly upregulated the <italic toggle="yes">Ccl2</italic> promoter activity, while the upregulation was abolished when the &#x003b2;&#x02010;catenin/TCF binding site was mutated (Figure&#x000a0;<xref rid="jsp270053-fig-0005" ref-type="fig">5C</xref>) in disc cells. We treated the cells with BIO (6&#x02010;bromoindirubin&#x02010;3&#x02032;oxime), a GSK&#x02010;3&#x003b2; inhibitor, and found that BIO, as well as IL&#x02010;1&#x003b2; significantly upregulated &#x003b2;&#x02010;catenin protein levels in rat AF and NP cells. Additionally, IL&#x02010;1&#x003b2; increased the protein and mRNA expression of CCL2 [<xref rid="jsp270053-bib-0043" ref-type="bibr">43</xref>], suggesting a potential IL&#x02010;1&#x003b2;&#x02009;&#x02192;&#x02009;&#x003b2;&#x02010;catenin&#x02009;&#x02192;&#x02009;CCL2 signaling pathway in disc cells (Figure&#x000a0;<xref rid="jsp270053-fig-0005" ref-type="fig">5D,E</xref>).</p><fig position="float" fig-type="FIGURE" id="jsp270053-fig-0004"><label>FIGURE 4</label><caption><p>&#x003b2;&#x02010;catenin and CCL2 expression was increased in <italic toggle="yes">Sox9</italic> deleted disc tissues. Immunohistochemistry data (L4/5, <italic toggle="yes">n</italic>&#x02009;=&#x02009;3, scale bar 100&#x02009;&#x003bc;m in A, 25&#x02009;&#x003bc;m in B) demonstrated that &#x003b2;&#x02010;catenin and CCL2 protein expression was markedly increased (yellow arrows and red arrows, right panel) in disc tissues from 4&#x02010;month&#x02010;old <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice when SOX9 protein expression was not detected by administration with tamoxifen (1&#x02009;mg/10&#x02009;g body weight, IP, daily for 5&#x02009;days) at 8&#x02009;weeks of age.</p></caption><graphic xlink:href="JSP2-8-e70053-g004" position="anchor" id="jats-graphic-9"/></fig><fig position="float" fig-type="FIGURE" id="jsp270053-fig-0005"><label>FIGURE 5</label><caption><p>&#x003b2;&#x02010;catenin and inflammatory cytokines in rat NP and AF disc cells. (A and B) Treatment of NP and AF cells with BIO (1&#x02009;&#x003bc;M) significantly up&#x02010;regulated <italic toggle="yes">Ccl2, TNF</italic>&#x003b1;, and <italic toggle="yes">Mmp13</italic> gene expression. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, unpaired Student <italic toggle="yes">t</italic>&#x02010;test, <italic toggle="yes">n</italic>&#x02009;=&#x02009;3. C. The construct of <italic toggle="yes">Ccl2</italic> promoter reporter harbors a consensus &#x003b2;&#x02010;catenin/TCF binding site, 5&#x02032;&#x02794;CTTTGAT&#x02010;3&#x02032; site located 1082&#x02009;bp upstream of the transcription initiation start in rat <italic toggle="yes">Ccl2 promoter</italic>. BIO treatment increased <italic toggle="yes">Ccl2</italic> promoter activity in rat disc cells. Mutation of the &#x003b2;&#x02010;catenin/TCF binding site (5&#x02032;&#x02010;CTTTGAT&#x02010;3&#x02032;&#x02794; 5&#x02032;&#x02010;CTTTGCG&#x02010;3&#x02032;) abolished BIO&#x02010;induced <italic toggle="yes">Ccl2</italic> promoter activity in rat disc cells. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, one&#x02010;way ANOVA followed by Tukey HSD test, <italic toggle="yes">n</italic>&#x02009;=&#x02009;4. (D and E) A GSK&#x02010;3&#x003b2; inhibitor, BIO (6&#x02010;bromoindirubin&#x02010;30&#x02010;oxime), and IL&#x02010;1&#x003b2; up&#x02010;regulated &#x003b2;&#x02010;catenin protein levels in NP and AF cells. Rat NP and AF cell lines were treated with BIO (GSK&#x02010;3&#x003b2; inhibitor, 1 &#x003bc;M) and IL&#x02010;1&#x003b2; (5&#x02009;ng/mL) for 24&#x02009;h. Both BIO and IL&#x02010;1&#x003b2; significantly up&#x02010;regulated &#x003b2;&#x02010;catenin protein levels in NP and AF cells.</p></caption><graphic xlink:href="JSP2-8-e70053-g006" position="anchor" id="jats-graphic-11"/></fig></sec></sec><sec sec-type="discussion" id="jsp270053-sec-0023"><label>4</label><title>Discussion</title><p>The aim of our study was to investigate the role of Sox9 in maintaining intervertebral disc (IVD) health and to explore how its deletion impacts disc degeneration and pain behaviors. While we acknowledge that Sox9 mutations are not a common cause of IVD degeneration in clinical settings, our Sox9cKO mouse model provides a valuable framework to study the molecular and cellular mechanisms of degeneration, including disrupted matrix organization and cellular dysfunction, which are relevant to natural degenerative processes. MicroCT analysis further indicated intervertebral disc degeneration. All phenotypes were consistent with our previous report [<xref rid="jsp270053-bib-0018" ref-type="bibr">18</xref>] and those of other groups employing Sox9 conditional deletion mice [<xref rid="jsp270053-bib-0028" ref-type="bibr">28</xref>, <xref rid="jsp270053-bib-0032" ref-type="bibr">32</xref>]. To explore the pain mechanisms related to intervertebral disc degeneration, we performed pain assessments using this mouse model. As shown in Figure&#x000a0;<xref rid="jsp270053-fig-0003" ref-type="fig">3</xref>, <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice exhibited a reduction in the von Frey threshold, indicating increased sensitivity to mechanical stimuli. In addition, the LABORAS assessment revealed significant differences between <italic toggle="yes">Cre&#x02212;</italic> and <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice, specifically reduced rearing frequency, travel distance, average walking speed, and rearing duration. These findings indicate decreased exploratory behavior, limited overall movement, and impaired locomotor activity. While <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice also have knee joint OA and temporomandibular joint OA (data not shown), which could affect these assessments, our primary aim was to identify pain&#x02010;related molecular mechanisms. The upregulation of GDNF in degenerated disc tissues suggests its involvement in the pain mechanism associated with disc degeneration in this mouse model (Figure&#x000a0;<xref rid="jsp270053-fig-0003" ref-type="fig">3</xref>). Although many studies have used this mouse model [<xref rid="jsp270053-bib-0005" ref-type="bibr">5</xref>, <xref rid="jsp270053-bib-0018" ref-type="bibr">18</xref>, <xref rid="jsp270053-bib-0032" ref-type="bibr">32</xref>], our pain assessment is the first to be reported in <italic toggle="yes">Sox9</italic>
<sup>
<italic toggle="yes">cKO</italic>
</sup> mice. To explore the pain mechanisms in intervertebral disc degeneration in this mouse model, a key focus is on the downstream effects of Sox9. Previous evidence suggests that Sox9 plays a pivotal role in regulating &#x003b2;&#x02010;catenin expression and activity. Sox9 repression of &#x003b2;&#x02010;catenin is necessary for the proper differentiation of mesenchymal cells into chondrocytes [<xref rid="jsp270053-bib-0030" ref-type="bibr">30</xref>]. Sox9 can inhibit &#x003b2;&#x02010;catenin/TCF transcriptional activity&#x000a0;[<xref rid="jsp270053-bib-0044" ref-type="bibr">44</xref>] and interacts with the &#x003b2;&#x02010;catenin destruction complex, promoting &#x003b2;&#x02010;catenin degradation [<xref rid="jsp270053-bib-0031" ref-type="bibr">31</xref>]. However, recent reports indicate that Sox9 represses Wnt/&#x003b2;&#x02010;catenin signaling independently of the &#x003b2;&#x02010;catenin destruction complex by regulating MAML2 [<xref rid="jsp270053-bib-0045" ref-type="bibr">45</xref>]. As expected, our study showed that the deletion of Sox9 results in elevated &#x003b2;&#x02010;catenin levels in intervertebral discs (Figure&#x000a0;<xref rid="jsp270053-fig-0004" ref-type="fig">4</xref>). Following the examination of &#x003b2;&#x02010;catenin expression, we investigated CCL2 due to its intricate link to pain mechanisms.</p><p>Previous studies demonstrated that &#x003b2;&#x02010;catenin regulates the expression of CCL2 [<xref rid="jsp270053-bib-0034" ref-type="bibr">34</xref>, <xref rid="jsp270053-bib-0037" ref-type="bibr">37</xref>], highlighting its importance in inflammatory and pain responses. CCL2, also known as monocyte chemoattractant protein 1 (MCP&#x02010;1), plays a crucial role in recruiting monocytes and other immune cells to sites of inflammation, and its elevated levels have been associated with heightened pain sensitivity and neuropathic pain [<xref rid="jsp270053-bib-0046" ref-type="bibr">46</xref>, <xref rid="jsp270053-bib-0047" ref-type="bibr">47</xref>, <xref rid="jsp270053-bib-0048" ref-type="bibr">48</xref>]. Recent research has provided evidence that &#x003b2;&#x02010;catenin signaling can regulate CCL2 expression in breast cancer cells [<xref rid="jsp270053-bib-0034" ref-type="bibr">34</xref>, <xref rid="jsp270053-bib-0049" ref-type="bibr">49</xref>] and in the human chondrocyte cell line [<xref rid="jsp270053-bib-0037" ref-type="bibr">37</xref>]. Our results showed that CCL2 is also increased in Sox9&#x02010;deleted tissues, suggesting that the dysregulation of the &#x003b2;&#x02013;catenin&#x02013;CCL2 pathway due to Sox9 deletion may drive the inflammatory response and pain observed in degenerative disc disease. Next, we confirmed that &#x003b2;&#x02010;catenin regulates CCL2 expression in our established disc cell line. Using a reporter construct of the CCL2 promoter, we demonstrated that &#x003b2;&#x02010;catenin can regulate CCL2 expression. We anticipate &#x003b2;&#x02010;catenin to regulate CCL2 expression by binding to the CCL2 promoter region, as reported in other cell lines [<xref rid="jsp270053-bib-0037" ref-type="bibr">37</xref>]. As shown in Figure&#x000a0;<xref rid="jsp270053-supitem-0001" ref-type="supplementary-material">S1</xref>, RNA&#x02010;Seq analysis data showed that CCL2 expression is significantly increased in Sox9&#x02010;deleted chondrocytes, indicating Sox9's involvement in regulating CCL2 expression.</p><p>However, the &#x003b2;&#x02010;catenin mRNA level was not dramatically increased according to the RNA&#x02010;Seq data. This suggests that Sox9 may regulate &#x003b2;&#x02010;catenin at a protein level. The increased CCL2 expression observed in Sox9&#x02010;deleted chondrocytes could be influenced by elevated &#x003b2;&#x02010;catenin protein levels, despite unchanged mRNA levels. Further, we identify glial cell line&#x02013;derived neurotrophic factor (GDNF) as a potential mediator of nociceptive hypersensitivity in the context of inflammation (Figure&#x000a0;<xref rid="jsp270053-fig-0003" ref-type="fig">3</xref>). Our data show GDNF upregulation in degenerated discs due to SOX9 deletion. In future studies, to comprehensively analyze pain mechanisms in disc tissues, several additional analyses should be conducted to quantify other key pain&#x02010;related molecules such as IL&#x02010;1&#x003b2;, TNF&#x02010;&#x003b1;, NGF, and BDNF within the disc tissues.</p><p>Our study has several major strengths that enhance the understanding of intervertebral disc degeneration and its associated pain mechanisms, particularly the &#x003b2;&#x02010;catenin and CCL2 pathways, by utilizing the <italic toggle="yes">Agc1&#x02010;CreERT2/Sox9</italic>
<sup>
<italic toggle="yes">flox/flox</italic>
</sup> mouse model. However, we also acknowledge the limitations that should be addressed in future studies. First, in our study, we treated mice with tamoxifen at 8&#x02009;weeks of age. To better model adult mice and potentially observe more pronounced phenotypes, future studies should consider injecting tamoxifen at 12&#x02009;weeks of age. Despite this difference, our findings on intervertebral disc degeneration are consistent with previous studies [<xref rid="jsp270053-bib-0028" ref-type="bibr">28</xref>, <xref rid="jsp270053-bib-0032" ref-type="bibr">32</xref>] that injected tamoxifen at 12&#x02009;weeks. Second, our mouse model also exhibits knee OA and TMJ OA phenotypes, which could confound the interpretation of pain specifically associated with intervertebral disc degeneration. To address this, future research should focus on analyzing pain signaling in a lumbar spine instability mouse model to directly associate disc degeneration with pain. Finally, to confirm that ectopic expression of Sox9 can prevent inflammation and alleviate pain through the mediation of the &#x003b2;&#x02010;catenin/CCL2 pathways, additional experiments are necessary. These should include overexpression studies and functional assays to validate the therapeutic potential of targeting Sox9 in mitigating disc degeneration&#x02010;associated pain.</p></sec><sec sec-type="conclusions" id="jsp270053-sec-0024"><label>5</label><title>Conclusions</title><p>This study demonstrates that Sox9 deletion leads to severe intervertebral disc degeneration, characterized by disrupted matrix organization and increased inflammation, without mechanical herniation. Elevated &#x003b2;&#x02010;catenin and CCL2 levels in Sox9&#x02010;deleted tissues suggest that the &#x003b2;&#x02010;catenin&#x02010;CCL2 pathway plays a crucial role in the inflammatory response and pain associated with disc degeneration. Pain assessments revealed increased sensitivity to mechanical stimuli and decreased locomotor activity in the mouse model. Future studies should focus on adult mice, utilize lumbar spine instability models, and investigate the therapeutic potential of targeting Sox9 to mitigate pain through the &#x003b2;&#x02010;catenin/CCL2 pathways.</p></sec><sec id="jsp270053-sec-0025"><title>Author Contributions</title><p>K.A., A.C., H.S.A., and C.&#x02010;d.O. contributed to the conception and design of the work. K.A., A.C., F.K., J.A., S.S., and C.&#x02010;d.O. contributed to data acquisition and analysis. K.A., A.C., F.K., H.S.A., D.S., and C.&#x02010;d.O. contributed to the interpretation of the data and manuscript preparation. All co&#x02010;authors have reviewed and approved the final version of this manuscript for publication.</p></sec><sec sec-type="COI-statement" id="jsp270053-sec-0027"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="jsp270053-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1:</bold>
<italic toggle="yes">Agc1&#x02010;CreERT2</italic> could efficiently target different types of cells in disc tissue. Agc1&#x02010;CreERT2 could efficiently target different types of cells in disc tissue (L4/5, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5, scale bar 100&#x02009;&#x003bc;m). <italic toggle="yes">Agc1</italic>&#x02010;CreERT2 mice were bred with ROSA<sup>
<italic toggle="yes">mTmG</italic>
</sup> reporter mice. The resulting <italic toggle="yes">Agc1</italic>&#x02010;<italic toggle="yes">CreERT2</italic>;ROSA<sup>
<italic toggle="yes">mTmG</italic>
</sup> mice were administered with tamoxifen (1&#x02009;mg/10&#x02009;g body weight, IP, daily for 5&#x02009;days) at 2&#x02009;weeks of age and sacrificed at the age of 4&#x02010;week&#x02010;old. The result of fluorescence microscope analysis showed that <italic toggle="yes">Agc1</italic>&#x02010;<italic toggle="yes">CreERT2</italic> mice mainly target growth plate cartilage cells (yellow arrowhead), NP cells (white arrowhead), and AF cells (pink arrowhead).</p><p>
<bold>Figure S2:</bold>
<italic toggle="yes">Ccl2</italic> gene expression is significantly increased in <italic toggle="yes">Sox9</italic>&#x02010;deleted chondrocytes. RNA&#x02010;Seq analysis compared the RNA expression profiles of primary <italic toggle="yes">Sox9</italic> flox/flox mouse chondrocytes infected with Ad&#x02010;CMV&#x02010;Cre to those infected with a control adenovirus. The results indicated that when the levels of Sox9 mRNA were decreased by infection with Ad&#x02010;CMV&#x02010;Cre, <italic toggle="yes">Ccl2</italic> expression was significantly increased, as shown by log2 differential expression (DE). However, the level of &#x003b2;&#x02010;catenin expression did not significantly change.</p></caption><media xlink:href="JSP2-8-e70053-s001.docx"/></supplementary-material></sec></body><back><ack id="jsp270053-sec-0026"><title>Acknowledgments</title><p>This work was supported by the National Institutes of Health Grants RO3 AG061460 and Searle Innovation Grant to C.&#x02010;d.O.</p></ack><ref-list content-type="cited-references" id="jsp270053-bibl-0001"><title>References</title><ref id="jsp270053-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jsp270053-cit-0001">
<string-name>
<given-names>V. M.</given-names>
<surname>Ravindra</surname>
</string-name>, <string-name>
<given-names>S. S.</given-names>
<surname>Senglaub</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Rattani</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume</article-title>,&#x0201d; <source>Global Spine Journal</source>
<volume>8</volume>, no. <issue>8</issue> (<year>2018</year>): <fpage>784</fpage>&#x02013;<lpage>794</lpage>, <pub-id pub-id-type="doi">10.1177/2192568218770769</pub-id>.<pub-id pub-id-type="pmid">30560029</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jsp270053-cit-0002">
<collab collab-type="authors">Collaborators GBDOMD</collab>
, &#x0201c;<article-title>Global, Regional, and National Burden of Other Musculoskeletal Disorders, 1990&#x02013;2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021</article-title>,&#x0201d; <source>Lancet Rheumatology</source>
<volume>5</volume>, no. <issue>11</issue> (<year>2023</year>): <fpage>e670</fpage>&#x02013;<lpage>e682</lpage>, <pub-id pub-id-type="doi">10.1016/S2665-9913(23)00232-1</pub-id>.<pub-id pub-id-type="pmid">37927903</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jsp270053-cit-0003">
<collab collab-type="authors">Collaborators GBDF</collab>
, &#x0201c;<article-title>Burden of Disease Scenarios for 204 Countries and Territories, 2022&#x02010;2050: A Forecasting Analysis for the Global Burden of Disease Study 2021</article-title>,&#x0201d; <source>Lancet</source>
<volume>403</volume>, no. <issue>10440</issue> (<year>2024</year>): <fpage>2204</fpage>&#x02013;<lpage>2256</lpage>, <pub-id pub-id-type="doi">10.1016/S0140-6736(24)00685-8</pub-id>.<pub-id pub-id-type="pmid">38762325</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jsp270053-cit-0004">
<string-name>
<given-names>K.</given-names>
<surname>Fujii</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yamazaki</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Kang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Discogenic Back Pain: Literature Review of Definition, Diagnosis, and Treatment</article-title>,&#x0201d; <source>JBMR Plus</source>
<volume>3</volume>, no. <issue>5</issue> (<year>2019</year>): <elocation-id>e10180</elocation-id>, <pub-id pub-id-type="doi">10.1002/jbm4.10180</pub-id>.<pub-id pub-id-type="pmid">31131347</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jsp270053-cit-0005">
<string-name>
<given-names>J. C.</given-names>
<surname>Lotz</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>Fields</surname>
</string-name>, and <string-name>
<given-names>E. C.</given-names>
<surname>Liebenberg</surname>
</string-name>, &#x0201c;<article-title>The Role of the Vertebral End Plate in Low Back Pain</article-title>,&#x0201d; <source>Global Spine Journal</source>
<volume>3</volume>, no. <issue>3</issue> (<year>2013</year>): <fpage>153</fpage>&#x02013;<lpage>164</lpage>, <pub-id pub-id-type="doi">10.1055/s-0033-1347298</pub-id>.<pub-id pub-id-type="pmid">24436866</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jsp270053-cit-0006">
<string-name>
<given-names>G.</given-names>
<surname>Pattappa</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Peroglio</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Wismer</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Alini</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Grad</surname>
</string-name>, &#x0201c;<article-title>Diversity of Intervertebral Disc Cells: Phenotype and Function</article-title>,&#x0201d; <source>Journal of Anatomy</source>
<volume>221</volume>, no. <issue>6</issue> (<year>2012</year>): <fpage>480</fpage>&#x02013;<lpage>496</lpage>, <pub-id pub-id-type="doi">10.1111/j.1469-7580.2012.01521.x</pub-id>.<pub-id pub-id-type="pmid">22686699</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jsp270053-cit-0007">
<string-name>
<given-names>P. J.</given-names>
<surname>Roughley</surname>
</string-name>, &#x0201c;<article-title>Biology of Intervertebral Disc Aging and Degeneration: Involvement of the Extracellular Matrix</article-title>,&#x0201d; <source>Spine (Phila Pa 1976)</source>
<volume>29</volume>, no. <issue>23</issue> (<year>2004</year>): <fpage>2691</fpage>&#x02013;<lpage>2699</lpage>, <pub-id pub-id-type="doi">10.1097/01.brs.0000146101.53784.b1</pub-id>.<pub-id pub-id-type="pmid">15564918</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jsp270053-cit-0008">
<string-name>
<given-names>J. P.</given-names>
<surname>Urban</surname>
</string-name> and <string-name>
<given-names>S.</given-names>
<surname>Roberts</surname>
</string-name>, &#x0201c;<article-title>Degeneration of the Intervertebral Disc</article-title>,&#x0201d; <source>Arthritis Research and Therapy</source>
<volume>5</volume>, no. <issue>3</issue> (<year>2003</year>): <fpage>120</fpage>&#x02013;<lpage>130</lpage>, <pub-id pub-id-type="doi">10.1186/ar629</pub-id>.<pub-id pub-id-type="pmid">12723977</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jsp270053-cit-0009">
<string-name>
<given-names>T.</given-names>
<surname>Velnar</surname>
</string-name> and <string-name>
<given-names>L.</given-names>
<surname>Gradisnik</surname>
</string-name>, &#x0201c;<article-title>Endplate Role in the Degenerative Disc Disease: A Brief Review</article-title>,&#x0201d; <source>World Journal of Clinical Cases</source>
<volume>11</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>17</fpage>&#x02013;<lpage>29</lpage>, <pub-id pub-id-type="doi">10.12998/wjcc.v11.i1.17</pub-id>.<pub-id pub-id-type="pmid">36687189</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jsp270053-cit-0010">
<string-name>
<given-names>I.</given-names>
<surname>Sekiya</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Tsuji</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Koopman</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>SOX9 Enhances Aggrecan Gene Promoter/Enhancer Activity and Is Up&#x02010;Regulated by Retinoic Acid in a Cartilage&#x02010;Derived Cell Line, TC6</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>275</volume>, no. <issue>15</issue> (<year>2000</year>): <fpage>10738</fpage>&#x02013;<lpage>10744</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.275.15.10738</pub-id>.<pub-id pub-id-type="pmid">10753864</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jsp270053-cit-0011">
<string-name>
<given-names>I. L.</given-names>
<surname>Mohd Isa</surname>
</string-name>, <string-name>
<given-names>S. L.</given-names>
<surname>Teoh</surname>
</string-name>, <string-name>
<given-names>N. H.</given-names>
<surname>Mohd Nor</surname>
</string-name>, and <string-name>
<given-names>S. A.</given-names>
<surname>Mokhtar</surname>
</string-name>, &#x0201c;<article-title>Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>24</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>208</elocation-id>, <pub-id pub-id-type="doi">10.3390/ijms24010208</pub-id>.<pub-id pub-id-type="pmid">36613651</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jsp270053-cit-0012">
<string-name>
<given-names>A. E.</given-names>
<surname>Karchevskaya</surname>
</string-name>, <string-name>
<given-names>Y. M.</given-names>
<surname>Poluektov</surname>
</string-name>, and <string-name>
<given-names>V. A.</given-names>
<surname>Korolishin</surname>
</string-name>, &#x0201c;<article-title>Understanding Intervertebral Disc Degeneration: Background Factors and the Role of Initial Injury</article-title>,&#x0201d; <source>Biomedicine</source>
<volume>11</volume>, no. <issue>10</issue> (<year>2023</year>): <elocation-id>2714</elocation-id>, <pub-id pub-id-type="doi">10.3390/biomedicines11102714</pub-id>.</mixed-citation></ref><ref id="jsp270053-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jsp270053-cit-0013">
<string-name>
<given-names>Y.</given-names>
<surname>Kamachi</surname>
</string-name> and <string-name>
<given-names>H.</given-names>
<surname>Kondoh</surname>
</string-name>, &#x0201c;<article-title>Sox Proteins: Regulators of Cell Fate Specification and Differentiation</article-title>,&#x0201d; <source>Development</source>
<volume>140</volume>, no. <issue>20</issue> (<year>2013</year>): <fpage>4129</fpage>&#x02013;<lpage>4144</lpage>, <pub-id pub-id-type="doi">10.1242/dev.091793</pub-id>.<pub-id pub-id-type="pmid">24086078</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jsp270053-cit-0014">
<string-name>
<given-names>D. M.</given-names>
<surname>Bell</surname>
</string-name>, <string-name>
<given-names>K. K.</given-names>
<surname>Leung</surname>
</string-name>, <string-name>
<given-names>S. C.</given-names>
<surname>Wheatley</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>SOX9 Directly Regulates the Type&#x02010;II Collagen Gene</article-title>,&#x0201d; <source>Nature Genetics</source>
<volume>16</volume>, no. <issue>2</issue> (<year>1997</year>): <fpage>174</fpage>&#x02013;<lpage>178</lpage>, <pub-id pub-id-type="doi">10.1038/ng0697-174</pub-id>.<pub-id pub-id-type="pmid">9171829</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jsp270053-cit-0015">
<string-name>
<given-names>H.</given-names>
<surname>Yasuda</surname>
</string-name>, <string-name>
<given-names>C. D.</given-names>
<surname>Oh</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>de Crombrugghe</surname>
</string-name>, and <string-name>
<given-names>J. H.</given-names>
<surname>Kim</surname>
</string-name>, &#x0201c;<article-title>A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9&#x02010;Dependent Enhancer in Intron 6</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>292</volume>, no. <issue>2</issue> (<year>2017</year>): <fpage>528</fpage>&#x02013;<lpage>538</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.M116.758425</pub-id>.<pub-id pub-id-type="pmid">27881681</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jsp270053-cit-0016">
<string-name>
<given-names>L. C.</given-names>
<surname>Bridgewater</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Lefebvre</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>de Crombrugghe</surname>
</string-name>, &#x0201c;<article-title>Chondrocyte&#x02010;Specific Enhancer Elements in the Col11a2 Gene Resemble the Col2a1 Tissue&#x02010;Specific Enhancer</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>273</volume>, no. <issue>24</issue> (<year>1998</year>): <fpage>14998</fpage>&#x02013;<lpage>15006</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.273.24.14998</pub-id>.<pub-id pub-id-type="pmid">9614107</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jsp270053-cit-0017">
<string-name>
<given-names>W. F.</given-names>
<surname>Xie</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sakano</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Lefebvre</surname>
</string-name>, and <string-name>
<given-names>L. J.</given-names>
<surname>Sandell</surname>
</string-name>, &#x0201c;<article-title>Trans&#x02010;Activation of the Mouse Cartilage&#x02010;Derived Retinoic Acid&#x02010;Sensitive Protein Gene by Sox9</article-title>,&#x0201d; <source>Journal of Bone and Mineral Research</source>
<volume>14</volume>, no. <issue>5</issue> (<year>1999</year>): <fpage>757</fpage>&#x02013;<lpage>763</lpage>, <pub-id pub-id-type="doi">10.1359/jbmr.1999.14.5.757</pub-id>.<pub-id pub-id-type="pmid">10320524</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jsp270053-cit-0018">
<string-name>
<given-names>C. D.</given-names>
<surname>Oh</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Yasuda</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>SOX9 Directly Regulates CTGF/CCN2 Transcription in Growth Plate Chondrocytes and in Nucleus Pulposus Cells of Intervertebral Disc</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>6</volume> (<year>2016</year>): <elocation-id>29916</elocation-id>, <pub-id pub-id-type="doi">10.1038/srep29916</pub-id>.<pub-id pub-id-type="pmid">27436052</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jsp270053-cit-0019">
<string-name>
<given-names>W.</given-names>
<surname>Bi</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Deng</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>R. R.</given-names>
<surname>Behringer</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>de Crombrugghe</surname>
</string-name>, &#x0201c;<article-title>Sox9 Is Required for Cartilage Formation</article-title>,&#x0201d; <source>Nature Genetics</source>
<volume>22</volume>, no. <issue>1</issue> (<year>1999</year>): <fpage>85</fpage>&#x02013;<lpage>89</lpage>, <pub-id pub-id-type="doi">10.1038/8792</pub-id>.<pub-id pub-id-type="pmid">10319868</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jsp270053-cit-0020">
<string-name>
<given-names>J. W.</given-names>
<surname>Foster</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Dominguez&#x02010;Steglich</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Guioli</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Campomelic Dysplasia and Autosomal Sex Reversal Caused by Mutations in an SRY&#x02010;Related Gene</article-title>,&#x0201d; <source>Nature</source>
<volume>372</volume>, no. <issue>6506</issue> (<year>1994</year>): <fpage>525</fpage>&#x02013;<lpage>530</lpage>, <pub-id pub-id-type="doi">10.1038/372525a0</pub-id>.<pub-id pub-id-type="pmid">7990924</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jsp270053-cit-0021">
<string-name>
<given-names>T.</given-names>
<surname>Wagner</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wirth</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Meyer</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Autosomal Sex Reversal and Campomelic Dysplasia Are Caused by Mutations in and Around the SRY&#x02010;Related Gene SOX9</article-title>,&#x0201d; <source>Cell</source>
<volume>79</volume>, no. <issue>6</issue> (<year>1994</year>): <fpage>1111</fpage>&#x02013;<lpage>1120</lpage>, <pub-id pub-id-type="doi">10.1016/0092-8674(94)90041-8</pub-id>.<pub-id pub-id-type="pmid">8001137</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jsp270053-cit-0022">
<string-name>
<given-names>R.</given-names>
<surname>Kist</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Schrewe</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Balling</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Scherer</surname>
</string-name>, &#x0201c;<article-title>Conditional Inactivation of Sox9: A Mouse Model for Campomelic Dysplasia</article-title>,&#x0201d; <source>Genesis</source>
<volume>32</volume>, no. <issue>2</issue> (<year>2002</year>): <fpage>121</fpage>&#x02013;<lpage>123</lpage>, <pub-id pub-id-type="doi">10.1002/gene.10050</pub-id>.<pub-id pub-id-type="pmid">11857796</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jsp270053-cit-0023">
<string-name>
<given-names>H.</given-names>
<surname>Akiyama</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Chaboissier</surname>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Martin</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Schedl</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>de Crombrugghe</surname>
</string-name>, &#x0201c;<article-title>The Transcription Factor Sox9 Has Essential Roles in Successive Steps of the Chondrocyte Differentiation Pathway and Is Required for Expression of Sox5 and Sox6</article-title>,&#x0201d; <source>Genes and Development</source>
<volume>16</volume>, no. <issue>21</issue> (<year>2002</year>): <fpage>2813</fpage>&#x02013;<lpage>2828</lpage>, <pub-id pub-id-type="doi">10.1101/gad.1017802</pub-id>.<pub-id pub-id-type="pmid">12414734</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jsp270053-cit-0024">
<string-name>
<given-names>F.</given-names>
<surname>Barrionuevo</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Taketo</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Scherer</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Kispert</surname>
</string-name>, &#x0201c;<article-title>Sox9 Is Required for Notochord Maintenance in Mice</article-title>,&#x0201d; <source>Developmental Biology</source>
<volume>295</volume>, no. <issue>1</issue> (<year>2006</year>): <fpage>128</fpage>&#x02013;<lpage>140</lpage>, <pub-id pub-id-type="doi">10.1016/j.ydbio.2006.03.014</pub-id>.<pub-id pub-id-type="pmid">16678811</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jsp270053-cit-0025">
<string-name>
<given-names>H. E.</given-names>
<surname>Gruber</surname>
</string-name>, <string-name>
<given-names>H. J.</given-names>
<surname>Norton</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Ingram</surname>
</string-name>, and <string-name>
<given-names>E. N.</given-names>
<surname>Hanley</surname>, <suffix>Jr.</suffix>
</string-name>, &#x0201c;<article-title>The SOX9 Transcription Factor in the Human Disc: Decreased Immunolocalization With Age and Disc Degeneration</article-title>,&#x0201d; <source>Spine (Phila Pa 1976)</source>
<volume>30</volume>, no. <issue>6</issue> (<year>2005</year>): <fpage>625</fpage>&#x02013;<lpage>630</lpage>, <pub-id pub-id-type="doi">10.1097/01.brs.0000155420.01444.c6</pub-id>.<pub-id pub-id-type="pmid">15770176</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jsp270053-cit-0026">
<string-name>
<given-names>C. D.</given-names>
<surname>Oh</surname>
</string-name>, <string-name>
<given-names>H. J.</given-names>
<surname>Im</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Suh</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chee</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>An</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Chen</surname>
</string-name>, &#x0201c;<article-title>Rho&#x02010;Associated Kinase Inhibitor Immortalizes Rat Nucleus Pulposus and Annulus Fibrosus Cells: Establishment of Intervertebral Disc Cell Lines With Novel Approaches</article-title>,&#x0201d; <source>Spine (Phila Pa 1976)</source>
<volume>41</volume>, no. <issue>5</issue> (<year>2016</year>): <fpage>E255</fpage>&#x02013;<lpage>E261</lpage>, <pub-id pub-id-type="doi">10.1097/BRS.0000000000001235</pub-id>.<pub-id pub-id-type="pmid">26693672</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jsp270053-cit-0027">
<string-name>
<given-names>K.</given-names>
<surname>Khoshhal</surname>
</string-name> and <string-name>
<given-names>R. M.</given-names>
<surname>Letts</surname>
</string-name>, &#x0201c;<article-title>Orthopaedic Manifestations of Campomelic Dysplasia</article-title>,&#x0201d; <source>Clinical Orthopaedics and Related Research</source>
<volume>401</volume> (<year>2002</year>): <fpage>65</fpage>&#x02013;<lpage>74</lpage>, <pub-id pub-id-type="doi">10.1097/00003086-200208000-00010</pub-id>.</mixed-citation></ref><ref id="jsp270053-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jsp270053-cit-0028">
<string-name>
<given-names>S. P.</given-names>
<surname>Henry</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Liang</surname>
</string-name>, <string-name>
<given-names>K. C.</given-names>
<surname>Akdemir</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>de Crombrugghe</surname>
</string-name>, &#x0201c;<article-title>The Postnatal Role of Sox9 in Cartilage</article-title>,&#x0201d; <source>Journal of Bone and Mineral Research</source>
<volume>27</volume>, no. <issue>12</issue> (<year>2012</year>): <fpage>2511</fpage>&#x02013;<lpage>2525</lpage>, <pub-id pub-id-type="doi">10.1002/jbmr.1696</pub-id>.<pub-id pub-id-type="pmid">22777888</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jsp270053-cit-0029">
<string-name>
<given-names>J. H.</given-names>
<surname>Ryu</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>S. H.</given-names>
<surname>Kim</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Regulation of the Chondrocyte Phenotype by Beta&#x02010;Catenin</article-title>,&#x0201d; <source>Development</source>
<volume>129</volume>, no. <issue>23</issue> (<year>2002</year>): <fpage>5541</fpage>&#x02013;<lpage>5550</lpage>, <pub-id pub-id-type="doi">10.1242/dev.129.23.5541</pub-id>.<pub-id pub-id-type="pmid">12403723</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jsp270053-cit-0030">
<string-name>
<given-names>H.</given-names>
<surname>Akiyama</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Lyons</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Mori&#x02010;Akiyama</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Interactions Between Sox9 and Beta&#x02010;Catenin Control Chondrocyte Differentiation</article-title>,&#x0201d; <source>Genes and Development</source>
<volume>18</volume>, no. <issue>9</issue> (<year>2004</year>): <fpage>1072</fpage>&#x02013;<lpage>1087</lpage>, <pub-id pub-id-type="doi">10.1101/gad.1171104</pub-id>.<pub-id pub-id-type="pmid">15132997</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jsp270053-cit-0031">
<string-name>
<given-names>P.</given-names>
<surname>Dy</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Bhattaram</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sox9 Directs Hypertrophic Maturation and Blocks Osteoblast Differentiation of Growth Plate Chondrocytes</article-title>,&#x0201d; <source>Developmental Cell</source>
<volume>22</volume>, no. <issue>3</issue> (<year>2012</year>): <fpage>597</fpage>&#x02013;<lpage>609</lpage>, <pub-id pub-id-type="doi">10.1016/j.devcel.2011.12.024</pub-id>.<pub-id pub-id-type="pmid">22421045</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jsp270053-cit-0032">
<string-name>
<given-names>M.</given-names>
<surname>Tsingas</surname>
</string-name>, <string-name>
<given-names>O. K.</given-names>
<surname>Ottone</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Haseeb</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sox9 Deletion Causes Severe Intervertebral Disc Degeneration Characterized by Apoptosis, Matrix Remodeling, and Compartment&#x02010;Specific Transcriptomic Changes</article-title>,&#x0201d; <source>Matrix Biology</source>
<volume>94</volume> (<year>2020</year>): <fpage>110</fpage>&#x02013;<lpage>133</lpage>, <pub-id pub-id-type="doi">10.1016/j.matbio.2020.09.003</pub-id>.<pub-id pub-id-type="pmid">33027692</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jsp270053-cit-0033">
<string-name>
<given-names>I. P.</given-names>
<surname>Melgoza</surname>
</string-name>, <string-name>
<given-names>S. S.</given-names>
<surname>Chenna</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tessier</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Development of a Standardized Histopathology Scoring System Using Machine Learning Algorithms for Intervertebral Disc Degeneration in the Mouse Model&#x02010;An ORS Spine Section Initiative</article-title>,&#x0201d; <source>JOR Spine</source>
<volume>4</volume>, no. <issue>2</issue> (<year>2021</year>): <elocation-id>e1164</elocation-id>, <pub-id pub-id-type="doi">10.1002/jsp2.1164</pub-id>.<pub-id pub-id-type="pmid">34337338</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jsp270053-cit-0034">
<string-name>
<given-names>M.</given-names>
<surname>Mestdagt</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Polette</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Buttice</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Transactivation of MCP&#x02010;1/CCL2 by Beta&#x02010;Catenin/TCF&#x02010;4 in Human Breast Cancer Cells</article-title>,&#x0201d; <source>International Journal of Cancer</source>
<volume>118</volume>, no. <issue>1</issue> (<year>2006</year>): <fpage>35</fpage>&#x02013;<lpage>42</lpage>, <pub-id pub-id-type="doi">10.1002/ijc.21291</pub-id>.<pub-id pub-id-type="pmid">16003740</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jsp270053-cit-0035">
<string-name>
<given-names>K.</given-names>
<surname>Masuda</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Aota</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Muehleman</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Novel Rabbit Model of Mild, Reproducible Disc Degeneration by an Anulus Needle Puncture: Correlation Between the Degree of Disc Injury and Radiological and Histological Appearances of Disc Degeneration</article-title>,&#x0201d; <source>Spine (Phila Pa 1976)</source>
<volume>30</volume>, no. <issue>1</issue> (<year>2005</year>): <fpage>5</fpage>&#x02013;<lpage>14</lpage>, <pub-id pub-id-type="doi">10.1097/01.brs.0000148152.04401.20</pub-id>.<pub-id pub-id-type="pmid">15626974</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jsp270053-cit-0036">
<string-name>
<given-names>P.</given-names>
<surname>Shi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chee</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>P. H.</given-names>
<surname>Chou</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zhu</surname>
</string-name>, and <string-name>
<given-names>H. S.</given-names>
<surname>An</surname>
</string-name>, &#x0201c;<article-title>Therapeutic Effects of Cell Therapy With Neonatal Human Dermal Fibroblasts and Rabbit Dermal Fibroblasts on Disc Degeneration and Inflammation</article-title>,&#x0201d; <source>Spine Journal</source>
<volume>19</volume>, no. <issue>1</issue> (<year>2019</year>): <fpage>171</fpage>&#x02013;<lpage>181</lpage>, <pub-id pub-id-type="doi">10.1016/j.spinee.2018.08.005</pub-id>.</mixed-citation></ref><ref id="jsp270053-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jsp270053-cit-0037">
<string-name>
<given-names>K.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Jiang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Upregulation of Beta&#x02010;Catenin Signaling Represents a Single Common Pathway Leading to the Various Phenotypes of Spinal Degeneration and Pain</article-title>,&#x0201d; <source>Bone Research</source>
<volume>11</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>18</fpage>, <pub-id pub-id-type="doi">10.1038/s41413-023-00253-0</pub-id>.<pub-id pub-id-type="pmid">37059724</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jsp270053-cit-0038">
<string-name>
<given-names>S.</given-names>
<surname>Nencini</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ringuet</surname>
</string-name>, <string-name>
<given-names>D. H.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Greenhill</surname>
</string-name>, and <string-name>
<given-names>J. J.</given-names>
<surname>Ivanusic</surname>
</string-name>, &#x0201c;<article-title>GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain</article-title>,&#x0201d; <source>Journal of Neuroscience</source>
<volume>38</volume>, no. <issue>21</issue> (<year>2018</year>): <fpage>4899</fpage>&#x02013;<lpage>4911</lpage>, <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0421-18.2018</pub-id>.<pub-id pub-id-type="pmid">29712778</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jsp270053-cit-0039">
<string-name>
<given-names>C. D.</given-names>
<surname>Paavola</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Hemmerich</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Grunberger</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Monomeric Monocyte Chemoattractant Protein&#x02010;1 (MCP&#x02010;1) Binds and Activates the MCP&#x02010;1 Receptor CCR2B</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>273</volume>, no. <issue>50</issue> (<year>1998</year>): <fpage>33157</fpage>&#x02013;<lpage>33165</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.273.50.33157</pub-id>.<pub-id pub-id-type="pmid">9837883</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jsp270053-cit-0040">
<string-name>
<given-names>H.</given-names>
<surname>Raghu</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Lepus</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>CCL2/CCR2, but Not CCL5/CCR5, Mediates Monocyte Recruitment, Inflammation and Cartilage Destruction in Osteoarthritis</article-title>,&#x0201d; <source>Annals of the Rheumatic Diseases</source>
<volume>76</volume>, no. <issue>5</issue> (<year>2017</year>): <fpage>914</fpage>&#x02013;<lpage>922</lpage>, <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-210426</pub-id>.<pub-id pub-id-type="pmid">27965260</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jsp270053-cit-0041">
<string-name>
<given-names>J.</given-names>
<surname>Miotla Zarebska</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chanalaris</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Driscoll</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>CCL2 and CCR2 Regulate Pain&#x02010;Related Behaviour and Early Gene Expression in Post&#x02010;Traumatic Murine Osteoarthritis but Contribute Little to Chondropathy</article-title>,&#x0201d; <source>Osteoarthritis and Cartilage</source>
<volume>25</volume>, no. <issue>3</issue> (<year>2017</year>): <fpage>406</fpage>&#x02013;<lpage>412</lpage>, <pub-id pub-id-type="doi">10.1016/j.joca.2016.10.008</pub-id>.<pub-id pub-id-type="pmid">27746376</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jsp270053-cit-0042">
<string-name>
<given-names>C. D.</given-names>
<surname>Oh</surname>
</string-name>, <string-name>
<given-names>S. N.</given-names>
<surname>Maity</surname>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Lu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Identification of SOX9 Interaction Sites in the Genome of Chondrocytes</article-title>,&#x0201d; <source>PLoS One</source>
<volume>5</volume>, no. <issue>4</issue> (<year>2010</year>): <elocation-id>e10113</elocation-id>, <pub-id pub-id-type="doi">10.1371/journal.pone.0010113</pub-id>.<pub-id pub-id-type="pmid">20404928</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jsp270053-cit-0043">
<string-name>
<given-names>P. H.</given-names>
<surname>Chou</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chee</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Shi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Small Molecule Antagonist of C&#x02010;C Chemokine Receptor 1 (CCR1) Reduces Disc Inflammation in the Rabbit Model</article-title>,&#x0201d; <source>Spine Journal</source>
<volume>20</volume>, no. <issue>12</issue> (<year>2020</year>): <fpage>2025</fpage>&#x02013;<lpage>2036</lpage>, <pub-id pub-id-type="doi">10.1016/j.spinee.2020.07.001</pub-id>.</mixed-citation></ref><ref id="jsp270053-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jsp270053-cit-0044">
<string-name>
<given-names>L.</given-names>
<surname>Topol</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>T. F.</given-names>
<surname>Day</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Yang</surname>
</string-name>, &#x0201c;<article-title>Sox9 Inhibits Wnt Signaling by Promoting Beta&#x02010;Catenin Phosphorylation in the Nucleus</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>284</volume>, no. <issue>5</issue> (<year>2009</year>): <fpage>3323</fpage>&#x02013;<lpage>3333</lpage>, <pub-id pub-id-type="doi">10.1074/jbc.M808048200</pub-id>.<pub-id pub-id-type="pmid">19047045</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jsp270053-cit-0045">
<string-name>
<given-names>A.</given-names>
<surname>Sinha</surname>
</string-name>, <string-name>
<given-names>V. B.</given-names>
<surname>Fan</surname>
</string-name>, <string-name>
<given-names>A. B.</given-names>
<surname>Ramakrishnan</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Engelhardt</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Kennell</surname>
</string-name>, and <string-name>
<given-names>K. M.</given-names>
<surname>Cadigan</surname>
</string-name>, &#x0201c;<article-title>Repression of Wnt/&#x003b2;&#x02010;Catenin Signaling by SOX9 and Mastermind&#x02010;Like Transcriptional Coactivator 2</article-title>,&#x0201d; <source>Science Advances</source>
<volume>7</volume>, no. <issue>8</issue> (<year>2021</year>): <elocation-id>eabe0849</elocation-id>, <pub-id pub-id-type="doi">10.1126/sciadv.abe0849</pub-id>.<pub-id pub-id-type="pmid">33597243</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jsp270053-cit-0046">
<string-name>
<given-names>G. E.</given-names>
<surname>White</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>Iqbal</surname>
</string-name>, and <string-name>
<given-names>D. R.</given-names>
<surname>Greaves</surname>
</string-name>, &#x0201c;<article-title>CC Chemokine Receptors and Chronic Inflammation&#x02014;Therapeutic Opportunities and Pharmacological Challenges</article-title>,&#x0201d; <source>Pharmacological Reviews</source>
<volume>65</volume>, no. <issue>1</issue> (<year>2013</year>): <fpage>47</fpage>&#x02013;<lpage>89</lpage>, <pub-id pub-id-type="doi">10.1124/pr.111.005074</pub-id>.<pub-id pub-id-type="pmid">23300131</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="jsp270053-cit-0047">
<string-name>
<given-names>C.</given-names>
<surname>Abbadie</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Bhangoo</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>De Koninck</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Malcangio</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Melik&#x02010;Parsadaniantz</surname>
</string-name>, and <string-name>
<given-names>F. A.</given-names>
<surname>White</surname>
</string-name>, &#x0201c;<article-title>Chemokines and Pain Mechanisms</article-title>,&#x0201d; <source>Brain Research Reviews</source>
<volume>60</volume>, no. <issue>1</issue> (<year>2009</year>): <fpage>125</fpage>&#x02013;<lpage>134</lpage>, <pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.12.002</pub-id>.<pub-id pub-id-type="pmid">19146875</pub-id>
</mixed-citation></ref><ref id="jsp270053-bib-0048"><label>48</label><mixed-citation publication-type="miscellaneous" id="jsp270053-cit-0048">
<string-name>
<given-names>R. E.</given-names>
<surname>Walk</surname>
</string-name>, <string-name>
<given-names>K. S.</given-names>
<surname>Broz</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Jing</surname>
</string-name>, et&#x000a0;al., <article-title>&#x0201c;The Progression of Infiltrating Neurovascular Features and Chemokine Production of the Caudal Intervertebral Disc Following Injury,&#x0201d;</article-title>
<italic toggle="yes">bioRxiv</italic> (2024), <pub-id pub-id-type="doi">10.1101/2024.07.12.603182</pub-id>.</mixed-citation></ref><ref id="jsp270053-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="jsp270053-cit-0049">
<string-name>
<given-names>F.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Beta&#x02010;Catenin&#x02010;CCL2 Feedback Loop Mediates Crosstalk Between Cancer Cells and Macrophages That Regulates Breast Cancer Stem Cells</article-title>,&#x0201d; <source>Oncogene</source>
<volume>40</volume>, no. <issue>39</issue> (<year>2021</year>): <fpage>5854</fpage>&#x02013;<lpage>5865</lpage>, <pub-id pub-id-type="doi">10.1038/s41388-021-01986-0</pub-id>.<pub-id pub-id-type="pmid">34345015</pub-id>
</mixed-citation></ref></ref-list></back></article>